Preface
MicroRNAs in viral gene regulation
The mechanism of RNA interference (RNAi) was discovered in the nematode worm C. elegans in 1998. This mechanism was soon linked to the potent and sequence-specific antiviral responses observed in plants, a phenomenon long known by other names such as cosuppression, post transcriptional gene silencing, or quelling. The RNAi pathway is also well conserved in many eukaryotes including animals and participates in controlling cell development by regulating gene activity.
Amongst others, two types of small double-stranded RNA molecules -microRNA (miRNA) and small interfering RNA (siRNA) -are central to the RNAi mechanism. These small RNAs can bind to specific mRNAs and either increase or decrease their activity, for example by preventing a mRNA from producing a protein. Of note, the RNAi mechanism involves more than just RNA molecules. Cellular proteins that are important to RNAi include the Drosha and Dicer endonucleases that process double-stranded mi-/si-RNA molecules and the Argonaut proteins in the RNA-induced silencing complex (RISC) and their cofactors that trigger the cleavage or silencing of targeted mRNAs. Some of these players are illustrated in the cartoon on the cover.
The principal idea behind this special issue is to provide a collection of expertly written articles that address the interface between RNA interference and viruses. In particular, we focus on events that are triggered by miRNAs of viral or cellular origin. A wide variety of molecular mechanisms at the virus-RNAi interface are presented, and these insights will also advance the understanding of cellular RNAi pathways. Many examples are illustrated for cellular miRNAs that control or enhance virus replication. On the other hand, there are also several descriptions of viruses that encode their own miRNAs, which are either involved in the control of viral gene expression or the preparation of the host cell for optimal virus replication. To accomplish our goal, this special issue travels along different kingdoms from plants to humans and focuses on a variety of viruses, including several important human pathogens.
RNAi research has led to the development of novel tools for the control of gene expression in biological investigations or drug discovery. The aim of this compendium is to address a range of important fundamental issues with potential implications for application at the virushost interface. The articles provide up-to-date surveys of emerging and established concepts in the field of RNAi and how viruses modulate RNAi responses. As a powerful new technology, RNAi is emerging as an important modality that holds promise for the therapy of notoriously challenging clinical pathogens such as hepatitis C virus (HCV) and human immunodeficiency virus (HIV). We envision that the articles in this collection will be useful to a wide range of readers -from basic science students, to seasoned virologists and RNAi researchers, and to molecular scientists and clinicians interested in developing novel antiviral strategies. 
